EIF4EBP1 and breast carcinoma: Rutkovsky et al. showed that over-expression of EIF4EBP1 in breast cancer was associated with poor patient prognosis, and it’s silencing significantly inhibited breast cancer cell proliferation by promoting G1 cell cycle arrest [32].